Dr. Mark Mu-Quan Lin, MD

Dr. Mark Mu-Quan Lin, MD

Dr. Mark Mu-Quan Lin, MD

Languages: English
Fax: (855)354-3967

Contact this Provider:

  • Neurology
Conditions I Treat
  • ataxia
  • behcet syndrome
  • blurred vision
  • cervical dystonia
  • chorea
  • Show All
Procedures I Perform
  • botox for dystonia
  • botox for hemifacial spasm
  • botox for migraines
  • botox for spasticity
  • botulinum toxin for movement disorders
  • Show All
About the Provider

Board-certified in neurology, Mark Lin, MD, PhD, serves as Director of Movement Disorders at MedStar Washington Hospital Center. His background in immunology is influential to his research and making advances in patient care.

Dr. Lin is highly regarded in the treatment and research of management for movement disorders with special expertise in the programming of deep brain stimulators for the treatment of Parkinson's disease, other types of tremor, and dystonia. He is also considered highly skilled in the use of botulinum therapy for the treatment of movement disorders, limb spasticity and chronic migraine.

Dr. Lin's work has been published in prominent clinical and scientific journals. A special focus of his current research is the prevention of levodopa-related dyskinesia and motor fluctuations in Parkinson's disease. Over the years, he has developed a prevention strategy for levodopa induced motor complications. He is as an associate professor at Georgetown University, participating in clinical teaching and clinical research.

After earning his medical degree from what is now known as Guangdong Medical University in Guangdong, China, Dr. Lin completed an MS and PhD at Albert Einstein College of Medicine followed by a residency in neurology at the same institution. Post-graduate training in movement disorders followed at the New York Neurological Institute, Columbia University.

  • Fellowship Program: Columbia University (2002)
  • Residency Program: Albert Einstein College of Medicine (2001)
  • Graduate Education: Albert Einstein School of Medicine (1997)
  • Medical School: Guangdong Medical College (1984)
  • Board Certification: American Board of Psychiatry and Neurology, Neurology
  • Lin, M.M., Laureno, R., (2019) When and how to start levodopa in the treatment of Parkinson disease. Open Access J Neurol Neurosurg. 11(2): 555808.
  • Lin, M.M., Laureno, R., (2019) Less pulsatile levodopa therapy (6 doses daily) is associated with a reduced incidence of dyskinesia. J Mov Disord. 12(1): 37-42.
  • Pal, G., Lin, M.M., Laureno, R., (2014) Asterixis: a study of 103 patients. Metabolic brain disease. 29(3): 813-24.
  • Erwin, A., Tornatore, C. and Lin, M. (2012) Profound alternating corticospinal tract enhancement in Neuro-Behcet's disease. Annals of Neurology 72(S16): S118.
  • Cooper, H.A., Thompson, E.C., Laureno, R., Fuisz, A., Mark, AS., Lin, M., Goldstein, S.A., (2009) Subclinical brain embolization in left-side infective endocarditis. Circulation. 120(7): 585-91.
  • Green, N.S. Lin, M.M., and Scharff, M.D. , (1998) Immunoglobulin hypermutation in cultured cells. Immunol. Rev. 162:77-87.
  • Green, N.S. Lin, M.M., and Scharff, M.D. , (1998) Somatic hypermutation of antibody genes: a hot spot warms up. Bioessays 20:227-234.
  • Lin, M.M., Green, N.S. and Scharff, M.D., (1998) The effects of E, 3'  (hs1,2) and 3'  enhancers on mutation of an Ig-VDJ-C2a Ig heavy gene in cultured B cells. Int. Immunol. 10:1121-1129.
  • Lin, M., and Scharff, M.D. (1997) Antibody V region hypermutation in vitro. Einstein Quart. J. Biol. Med. 14:49.
  • Lin, M., Zhu, M. and Scharff, M.D. (1997) Sequence dependent hypermutation of immunoglobulin heavy chains in cultured B cells. Proc. Natl. Acad. Sci. USA 94:5284-5289.
  • Lin, M., Spira, G., and Scharff, M.D. (1996) Molecular comparison of cultured hybridoma cells that switch isotypes at high and low rates. Somatic Cell and Molecular Genetics 22:329-340.
  • Lin, M., Chang, C.J. and Green, N.S. (1996) A new method for estimating high mutation rates in cultured cells Mutation Research 351:105-116.
  • Chang, C.J. and Lin, M.Q. (1995) Statistical model of the fluctuation analysis in cell biology. Proceedings of the Biometrics Section of the American Statistical Association 455-460.
    MedStar Health Providers participate with a wide range of health insurance products. We accept self-pay patients and the insurances plans listed below. This list is not comprehensive, it is updated periodically and is subject to change. If you do not see your health insurance plan or product listed, or if you have any questions regarding MedStar Health’s participation with your health plan, please contact your health plan to verify participation with our providers.

    Since the MedStar Health providers span the District of Columbia, Maryland and Virginia regions, our participation with DC, Maryland and Virginia Medical Assistance programs varies by provider group. Please contact your MedStar Physician’s Office to assist with verifying Medical Assistance participation. If you are enrolled in a Medicaid Managed Care Organization, please contact your Medicaid health plan to verify participation.

Practice Locations
Member of Medical Staff
  • MedStar Washington Hospital Center
  • MedStar National Rehabilitation Hospital